On a mission to unlock the power of biotechnology and empower our global customers to get to milestones and market faster. Academics join for free! 🧫🧬👩🏻🔬
What does it mean to be on
#TeamScience
? Find out what Benchlings have to say about our mission and culture — and above all, why we’re so passionate about helping scientists power new possibilities for humanity.
Today we officially made our
#AlphaFold
integration (previously a beta feature) widely available to the Benchling community. Now scientists can easily predict 3D protein structures, all at the click of a button — and within Benchling. See what else is new:
#AlphaFold
signals how the world is redefining what science is and how it’s done. Today we're excited to launch our AlphaFold beta feature — for the first time, scientists can use
@DeepMind
's
#AI
program to predict protein structures directly in Benchling.
We're thrilled to announce our Series E. It's an honor to accelerate R&D at more than 1,000 organizations around the globe. This funding will help us continue to deliver innovation across the life sciences to solve some of our world's greatest problems.
We announced our Series F, which we’ll use to keep powering
#biotech
R&D. Check out
@business
to see how our customers are tackling humanity's most pressing challenges as they develop new medicines, crops & other breakthrough products faster than ever.👨🏾🔬👩🏼🔬
How is Dr.
@PracheeAC
Avasthi changing the new PI experience? Read about her take on peer mentorship, the power of preprints, and making junior faculty voices heard.
#AcademicTwitter
#phdchat
We are thrilled to announce our Series D and are honored to be named one of the next billion-dollar startups by
@Forbes
. As the world looks to scientists for hope, we stay committed to our original mission: To build tools that accelerate life-changing work
Great read on the evolution of synthetic biology startups and the massive growth opportunity within the sector! We see you
@Ginkgo
@Zymergen
@SentiBio
🙂
We know that switching from a paper lab notebook is hard. But according to
@dillinlab
, "you have to start using Benchling like a real scientist." 😆
Thanks for the shout-out and making the whole Benchling team laugh!
"We saw an opportunity: to build software that could not only keep up with the new speed of science but accelerate it." In this
@Forbes
interview, co-founder & CEO
@sajithw
shares how Benchling came to be the company it is today.
Today, we’re thrilled to announce our Series B funding, led by
@Benchmark
with participation from
@FPrimeCapital
. With our new partners’ expertise, we will continue to accelerate life science R&D at leading biotech and pharma organizations.
From California, to Korea, to the Netherlands, companies developing large molecule-based products rely on Benchling to accelerate R&D and generate unprecedented business insights.
Today is the 8th anniversary of Benchling’s founding! Take a trip down memory lane with us as we look back on the history of our jellyfish mascot, JeffyP.
Our newest case study with
@anagenex
covers one of the coolest cases of DNA-encoded libraries and
#ML
we've seen so far! Read here to learn how they're using Benchling to accelerate their drug discovery at a massively high throughput:
For the last week of
#Pride
month, we’re featuring a new LGBTQ+ scientist every day! Go check out their work and amplify their voices! Happy Pride 🏳️🌈🏳️🌈🌈
Today, we’re thrilled to announce we’ve acquired
@overwatchapp
! With this acquisition, Benchling will create the industry’s first comprehensive, cloud-native in vivo solution and help more
#biopharma
companies get products to the clinic faster. 1/5
Meet Benchtalk, a journal produced by Benchling. Benchtalk showcases the exciting work of life scientists from academia to industry, facilitates discourse among members of the life science community, and connects them to revolutionary ideas. Read Volume 1!
Today was a big day — we officially opened the doors at our brand new headquarters in San Francisco! For the first time in over two years, we are finally back ✨ in person ✨ at all three offices, including in Boston and Zürich. Welcome back, team!
#TeamBenchling
How cool is this? CRISPR-based editing has been done in space for the first time🚀 ! Astronauts have performed an experiment to study how the body repairs DNA damage from cosmic radiation in low gravity:
#CRISPR
Every
#biotech
faces the same problem with lab instrument data: customized data pipelines and a LOT of manual data transfer. That’s why we’re creating an open source library of data converters for standardizing instrument data.
Congratulations
@RecursionPharma
on your recent raise and new partnership with
@BayerPharma
! We're excited to see how
#machinelearning
will be used to change drug discovery and develop innovative therapeutics.
We're proud to share that Benchling's co-founders, Ashutosh Singhal and Sajith Wickramasekara, have been named to
@Inc
's annual 30 Under 30 list of the boldest young entrepreneurs!
Dr. Ross Wilson’s lab at the University of California, Berkeley and the Innovative Genomics Institute had a unique start: it was born out of an existing collaboration between UC Berkeley and Pfizer. Read more here.
#UCBerkeley
#IGI
#geneediting
The next scientist in our
#Pride
series: Dr. Noah
@NKWhiteman
is an Associate Professor at
@UCBerkeley
(
@berkeleyIB
). His group studies the molecular basis of adaptations arising from the ancient arms race between toxic plants and the animals and microbes that attack them.
The
#1
question we get asked today from biotechs, large and small: "How do I incorporate
#AI
/
#ML
into my R&D?" Here we share the main challenges — and how we've seen companies successfully overcome them. 1/🧵
Coding is now a core skill for biologists — and mostly it’s self-taught. Whether it's Python or R, scientists are coding to analyze data, automate workflows, and more. See what
@bitsinbio
and Cradle found about
#biotech
’s modern toolkit:
#AcademicTwitter
So proud to have our CEO Saji Wickramasekara included in this group of inspiring people leading change in the world. For the 10th anniversary of
@Forbes
' 30 Under 30, they selected 30 all-stars amongst the last decade of awardees:
Dr.
@MollyCWomack
is an Assistant Professor at Utah State University
@USUAggies
. Her lab focuses on comparing trait development, morphology, and function among species to better understand how diversity develops, how diversity evolves, and why it matters.
Hey
@dillinlab
, JeffyP is feeling pretty gray after watching The Notebook (). Everyone remembers their first crush, but we’ll have you backed up forever.
While we're continuously improving our product, we also host an annual ✨Polish Bash ✨, for our engineers to focus solely on small (but impactful) user-facing improvements. Last year, we shipped 108 items in a single week!
Follow the 🧵 to see what we accomplish this year!
Karmella Haynes, Associate Professor at Emory University, is employing synthetic biology to understand and modulate epigenetic responses to cancer. She is also an iGEM coach, an artist, and a fierce advocate for representation in science.
Thanks for including us in your list
@BioRender
! The Cloud is helping scientists work smarter and faster in all aspects of their research. DM us or check out to learn more.
Today, we were thrilled to officially open the doors at our new Boston office. For many, it’s their first day back since before the pandemic — and first time meeting each other in person. Couldn’t be more happier to see everyone’s smiling faces!
#TeamBenchling
Today, we're excited to announce our partnership with
@iGEM
! Benchling is proud to support iGEM teams and to work with the iGEM Foundation toward our shared goals of advancing biology and empowering scientists.
We're excited to share our Series C funding and what this means for our product, our customers, and our team! With this investment, we'll support deeper engagements with customers and empower more cutting-edge scientists.
To support scientists working on COVID-19, we have set up a webpage that points to sequences, protocols, and other work that have been shared by scientists for public use. We are actively taking contributions and will be updating this regularly.
To support scientists working on COVID-19, we have set up a webpage that points to sequences, protocols, and other work that have been shared by scientists for public use. We are actively taking contributions and will be updating this regularly.
Next in our
#Pride
series: Dr. Joseph Osmundson (
@reluctantlyjoe
) is a scientist & writer. He is a Clinical Assistant Prof at
@NYU_LS
and his research focuses on cellular microbiology and transcription machinery. His writing focuses on queer theory, whiteness, and sexual identity
“Biopharma is an industry that hasn’t really seen the benefits of digital transformation yet. But it’s the industry that needs it the most.” 🧬⚡🧪
Benchling CEO and co-founder Sajith Wickramasekara goes on
@BloombergTV
to discuss the state of tech adoption in
#biopharma
, new
10 years ago,
@sajithw
and
@daashu
set out to build better software for scientists. Today, we serve R&D teams around the world. As we celebrate our 10th anniversary, we’d like to thank our amazing team — so proud to be unlocking the power of
#biotech
with you.
#BenchlingTurns10
🎈
The number of companies using Benchling to power their R&D has more than doubled over the past year. It’s an honor to support their cutting-edge work, and we can’t wait to see what the new year brings.
@PairwisePL
@ArsenalBio
@SynBioBeta
Benchling believes it’s worth investing in the researchers of tomorrow. That’s why, for the 2nd year in a row, we’re excited to partner with an organization that is training and molding the next generation of synthetic biologists: the iGEM Foundation.
We’re beyond ecstatic to be featured on the
@Nasdaq
Tower in Times Square. It’s a true honor to be recognized by
@Wing_VC
and
@Nasdaq
as one of the top 10 mid-stage companies in enterprise tech.
Field trip to Times Square!
#TeamBenchling
was excited to visit
@Nasdaq
for a special announcement: We’re proud to be named to the
@Forbes
#Cloud100
. Thank you to our incredible team!
Congrats to our customer
@mammothbiosci
!
CasΦ is the first compact cas protein that cuts dsDNA. In addition to being more accurate, its tiny size means it could potentially unlock in vivo delivery, a large bottleneck currently facing gene editors.
We're humbled and thrilled to have expanded our HQ yesterday, opening up a new floor! A year and a half (and four offices) ago, Benchling was about 40 people. Now, the team is pushing 130, and we're working out of two floors in San Francisco and an office in Boston.
Ten years ago, co-founders
@sajithw
and
@daashu
wrote the very first lines of Benchling code. Today, we’re starting the new fiscal year with our (virtual) Company Kick Off – a celebration of how far we've come and planning for the year ahead. Let’s goooo!!! 🔥
"We just let the cancer cells tell us what types of genes they need in order to grow." A
#CRISPR
-based screen to identify therapeutic targets for acute myeloid lymphoma:
Synthetic biology demands well-characterized, reusable data. Hear how Dr. Susanna Sauret-Gueto has built a culture of strong data management and open, accessible data with
@_OpenPlant
, a plant synthetic biology initiative at the University of Cambridge.
Madelyn Meyers used Benchling in 2 jobs before joining Benchling - now, she helps other scientists turbocharge their research.
“You step into the scientist’s brain, live their life, and replicate it – more efficiently, with more powerful tools.”
Excellent blog from
@MammothBioSci
on CRISPR in agbio - folks often think about bioengineering applied to drug discovery, but applying to agriculture has huge potential impact on global nutrition and food security
Virtual collaboration is critical nowadays. Benchling is hosting a webinar series for
@iGEM
teams to show them how to design experiments remotely. Register for the first webinar, on Tuesday, May 5, here:
What if we could universally recombine, insert, delete, or invert any two pieces of DNA?
In back-to-back
@Nature
papers, we report the discovery of bridge RNAs and 3 atomic structures of the first natural RNA-guided recombinase - a new mechanism for programmable genome design
Today we officially made our
#AlphaFold
integration (previously a beta feature) widely available to the Benchling community. Now scientists can easily predict 3D protein structures, all at the click of a button — and within Benchling. See what else is new:
We're continually amazed by all the multi-talented folks at Benchling! Our running group alone has nearly 100 people in it – 6 of whom just ran the Cambridge Half Marathon this past weekend.
Congrats Russell, Tara, Kevin, Susie, Holli, and Laura from the Boston office! 🏃🏻♀️🏃🏽🏅
#RNA
therapeutics hold tremendous potential to impact human health, but we need R&D tools to design, study, and develop these drugs faster. That’s why we’re proud to launch the industry’s first complete solution for RNA R&D.
Wow!
@jgi
researchers have developed a high-throughput approach for mapping interactions between transcription factors & their target genes. In
@naturemethods
, they've generated 17k genome-wide binding maps for 354 TFs across 48 bacteria:
We recently sat down with
@Forbes
to discuss how modern software is changing life sciences R&D. Read about how the industry is adjusting to this new class of software.
Honored to be part of
@Forbes
’s
#Cloud100
- we’re bringing life sciences R&D into the cloud to accelerate the pace of innovation for the benefit of us all.